Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Neurobiology of Disease
|
December 3, 2014
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Depression and Anxiety
|
September 3, 2015
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L Johnson, Lauren M Federici, Stephanie D Fitz, et al.
Behavioural Brain Research
|
April 22, 2014
Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Jason M Uslaner, Christopher J Winrow, Anthony L Gotter, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2009
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D Cox, Georgia B McGaughey, Michael J Bogusky, et al.
Sleep
|
July 4, 2012
Altered sleep and affect in the neurotensin receptor 1 knockout mouse
Karrie Fitzpatrick, Christopher J Winrow, Anthony L Gotter, et al.
Journal of Neurogenetics
|
June 9, 2016
Pharmacological evaluation of orexin receptor antagonists in preclinical animal models of pain
Terrence McDonald, Hongyu A Liang, Raul Sanoja, et al.
Journal of Neurogenetics
|
March 4, 2014
Quantitative proteomics in laser capture microdissected sleep nuclei from rat brain
Ronald A Miller, Christopher J Winrow, Daniel S Spellman, et al.
Science Advances
|
July 28, 2018
Cross-species systems analysis identifies gene networks differentially altered by sleep loss and depression
Joseph R Scarpa, Peng Jiang, Vance D Gao, et al.
Brain Research
|
March 24, 2009
Refined anatomical isolation of functional sleep circuits exhibits distinctive regional and circadian gene transcriptional profiles
Christopher J Winrow, Keith Q Tanis, Alison M Rigby, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Neurobiology of Disease
|
December 3, 2014
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann, Weera Supronsinchai, Simon Akerman, et al.
Depression and Anxiety
|
September 3, 2015
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L Johnson, Lauren M Federici, Stephanie D Fitz, et al.
Behavioural Brain Research
|
April 22, 2014
Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Jason M Uslaner, Christopher J Winrow, Anthony L Gotter, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2009
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D Cox, Georgia B McGaughey, Michael J Bogusky, et al.
Sleep
|
July 4, 2012
Altered sleep and affect in the neurotensin receptor 1 knockout mouse
Karrie Fitzpatrick, Christopher J Winrow, Anthony L Gotter, et al.
Journal of Neurogenetics
|
June 9, 2016
Pharmacological evaluation of orexin receptor antagonists in preclinical animal models of pain
Terrence McDonald, Hongyu A Liang, Raul Sanoja, et al.
Journal of Neurogenetics
|
March 4, 2014
Quantitative proteomics in laser capture microdissected sleep nuclei from rat brain
Ronald A Miller, Christopher J Winrow, Daniel S Spellman, et al.
Science Advances
|
July 28, 2018
Cross-species systems analysis identifies gene networks differentially altered by sleep loss and depression
Joseph R Scarpa, Peng Jiang, Vance D Gao, et al.
Brain Research
|
March 24, 2009
Refined anatomical isolation of functional sleep circuits exhibits distinctive regional and circadian gene transcriptional profiles
Christopher J Winrow, Keith Q Tanis, Alison M Rigby, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Page
of 6